Adjuvant therapy of breast cancer - bisphosphonates.
Saarto
Tiina
T
Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland. tiina.saarto@hus.fi
D000970:Antineoplastic Agents / Q000009:adverse effects; D047072:Aromatase Inhibitors / Q000009:adverse effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced / Q000188:drug therapy; D013629:Tamoxifen / Q000009:adverse effects
D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D004164:Diphosphonates; D013629:Tamoxifen